These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 8875343

  • 1. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor.
    Sugrue MF.
    J Ocul Pharmacol Ther; 1996; 12(3):363-76. PubMed ID: 8875343
    [Abstract] [Full Text] [Related]

  • 2. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
    Sugrue MF, Gautheron P, Mallorga P, Nolan TE, Graham SL, Schwam H, Shepard KL, Smith RL.
    Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacological profiles of the potent carbonic anhydrase inhibitor dorzolamide hydrochloride, a topical antiglaucoma agent].
    Kobayashi M, Naito K.
    Nihon Yakurigaku Zasshi; 2000 Jun; 115(6):323-8. PubMed ID: 10948564
    [Abstract] [Full Text] [Related]

  • 4. MK-927: a topically active ocular hypotensive carbonic anhydrase inhibitor.
    Sugrue MF, Gautheron P, Grove J, Mallorga P, Viader MP, Schwam H, Baldwin JJ, Christy ME, Ponticello GS.
    J Ocul Pharmacol; 1990 Jun; 6(1):9-22. PubMed ID: 2362161
    [Abstract] [Full Text] [Related]

  • 5. Effects of topical 0.5% levobunolol alone or in association with 2% dorzolamide compared with a fixed combination of 0.5% timolol and 2% dorzolamide on intraocular pressure and heart rate in dogs without glaucoma.
    Scardillo A, Pugliese M, De Majo M, Niutta PP, Pugliese A.
    Vet Ther; 2010 Jun; 11(3):E1-6. PubMed ID: 20960417
    [Abstract] [Full Text] [Related]

  • 6. Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension.
    Balfour JA, Wilde MI.
    Drugs Aging; 1997 May; 10(5):384-403. PubMed ID: 9143858
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors.
    Sugrue MF.
    Prog Retin Eye Res; 2000 Jan; 19(1):87-112. PubMed ID: 10614682
    [Abstract] [Full Text] [Related]

  • 8. [Innovative glaucoma therapy. Glaucoma therapy with topical carbonic anhydrase inhibitors].
    Herkel U, Pfeiffer N.
    Ophthalmologe; 2001 Oct; 98(10):929-33. PubMed ID: 11699313
    [Abstract] [Full Text] [Related]

  • 9. [Ocular pulse amplitude, intraocular pressure and beta blocker/carbonic anhydrase inhibition in combined therapy of primary open-angle glaucoma].
    Schmidt KG, von Rückmann A, Becker R, Pillunat LE.
    Klin Monbl Augenheilkd; 1999 Dec; 215(6):361-6. PubMed ID: 10637801
    [Abstract] [Full Text] [Related]

  • 10. A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals.
    Sugrue MF, Mallorga P, Schwam H, Baldwin JJ, Ponticello GS.
    Curr Eye Res; 1990 Jun; 9(6):607-15. PubMed ID: 2117519
    [Abstract] [Full Text] [Related]

  • 11. Continuous intraocular pressure measurement by telemetry in alpha-chymotrypsin-induced glaucoma model in the rabbit: effects of timolol, dorzolamide, and epinephrine.
    Percicot CL, Schnell CR, Debon C, Hariton C.
    J Pharmacol Toxicol Methods; 1996 Dec; 36(4):223-8. PubMed ID: 9040114
    [Abstract] [Full Text] [Related]

  • 12. Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs.
    Gelatt KN, MacKay EO.
    Vet Ophthalmol; 2001 Mar; 4(1):61-7. PubMed ID: 11397321
    [Abstract] [Full Text] [Related]

  • 13. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor.
    Wilkerson M, Cyrlin M, Lippa EA, Esposito D, Deasy D, Panebianco D, Fazio R, Yablonski M, Shields MB.
    Arch Ophthalmol; 1993 Oct; 111(10):1343-50. PubMed ID: 8216014
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs.
    Plummer CE, MacKay EO, Gelatt KN.
    Vet Ophthalmol; 2006 Oct; 9(4):245-9. PubMed ID: 16771760
    [Abstract] [Full Text] [Related]

  • 15. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?
    Scozzafava A, Menabuoni L, Mincione F, Briganti F, Mincione G, Supuran CT.
    J Med Chem; 1999 Jul 15; 42(14):2641-50. PubMed ID: 10411484
    [Abstract] [Full Text] [Related]

  • 16. Carbonic anhydrase inhibitors. Part 71. Synthesis and ocular pharmacology of a new class of water-soluble, topically effective intraocular pressure lowering sulfonamides incorporating picolinoyl moieties.
    Supuran CT, Scozzafava A, Menabuoni L, Mincione F, Briganti F, Mincione G.
    Eur J Pharm Sci; 1999 Aug 15; 8(4):317-28. PubMed ID: 10425382
    [Abstract] [Full Text] [Related]

  • 17. Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity.
    de Leval X, Ilies M, Casini A, Dogné JM, Scozzafava A, Masini E, Mincione F, Starnotti M, Supuran CT.
    J Med Chem; 2004 May 20; 47(11):2796-804. PubMed ID: 15139757
    [Abstract] [Full Text] [Related]

  • 18. Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension.
    Gugleta K.
    Curr Med Res Opin; 2010 Jun 20; 26(6):1255-67. PubMed ID: 20350146
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of a topically administered carbonic anhydrase inhibitor (MK-927) in normotensive and glaucomatous beagles.
    King TC, Gum GG, Gelatt KN.
    Am J Vet Res; 1991 Dec 20; 52(12):2067-70. PubMed ID: 1789524
    [Abstract] [Full Text] [Related]

  • 20. Effects of topical application of a 2% solution of dorzolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs.
    Cawrse MA, Ward DA, Hendrix DV.
    Am J Vet Res; 2001 Jun 20; 62(6):859-63. PubMed ID: 11400841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.